Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution in Canada, to perform a Left Atrial Appendage Closure (LAAC) procedure.
The company is establishing a manufacturing plant in La Lima Free Zone, in Cartago, where it will manufacture cardiovascular products to serve global markets.